ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Illinois » Internal Medicine

Top Internal Medicine Prescribers in Illinois

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KHALID JAVED M.D.

Internal Medicine

13,899

$703K

324
221 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

26%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $60

DAVID BAUMBERGER M.D.

Internal Medicine

13,799

$631K

547
505 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$46
Average prescription price

Avg: $60

ROBERT GLOVSKY MD

Internal Medicine

13,771

$740K

456
383 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $60

MOHINA GUPTA MD

Internal Medicine

13,765

$721K

375
322 are 65+

10%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $60

SHAZIA DAUDI MD

Internal Medicine

13,752

$937K

410
357 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $60

SATISH BARNABAS MD

Internal Medicine

13,730

$773K

353
95 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 11%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $60

PHILIP BRANSHAW MD

Internal Medicine

13,715

$803K

503
424 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $60

ELIZABETH OBRIEN M.D.

Internal Medicine

13,707

$639K

436
348 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$47
Average prescription price

Avg: $60

JOSEPH KOWALCZYK MD

Internal Medicine

13,651

$626K

442
405 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

25%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$46
Average prescription price

Avg: $60

DANIEL SENSENG M.D.

Internal Medicine

13,646

$640K

551
476 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$47
Average prescription price

Avg: $60

CARL STRAUCH M.D.

Internal Medicine

13,636

$562K

421
378 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$41
Average prescription price

Avg: $60

CARY BORTNICK MD

Internal Medicine

13,593

$941K

509
409 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$69
Average prescription price

Avg: $60

LAWRENCE PANKAU MD

Internal Medicine

13,583

$724K

533
504 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $60

NADEEM ANSARI M.D.

Internal Medicine

13,538

$1M

410
368 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 25%

$74
Average prescription price

Avg: $60

PARESH PATEL M.D.

Internal Medicine

13,504

$837K

453
409 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $60

JOHN DORSEY MD

Internal Medicine

13,493

$816K

645
541 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $60

AZRA OMEROVIC M.D.

Internal Medicine

13,485

$568K

623
535 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$42
Average prescription price

Avg: $60

EMMANUEL ALZONA M.D.

Internal Medicine

13,381

$952K

340
251 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$71
Average prescription price

Avg: $60

WILLIAM HUFFSTUTLER MD

Internal Medicine

13,369

$761K

312
260 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $60

MARIANNA TSARAN M.D.

Internal Medicine

13,364

$848K

246
234 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$63
Average prescription price

Avg: $60

DAVID ADE MD

Internal Medicine

13,330

$742K

813
681 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $60

SRILAKSHMI VEMAREDDY M.D.

Internal Medicine

13,225

$817K

384
310 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $60

DORIS HEIN M.D.

Internal Medicine

13,209

$541K

599
522 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 25%

$41
Average prescription price

Avg: $60

DAVID REEM MD

Internal Medicine

13,207

$735K

567
529 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $60

CHRISTOPHER GREEN M.D.

Internal Medicine

13,162

$1.1M

593
541 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 25%

$83
Average prescription price

Avg: $60

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank